BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10621157)

  • 1. Is there a market for PBMCs (pharmacy benefit management company) abroad?
    Fine A
    Exec Solut Healthc Manag; 1999 Sep; 2(9):2-3. PubMed ID: 10621157
    [No Abstract]   [Full Text] [Related]  

  • 2. The evolving pharmacy benefit market.
    Navarro RP
    Med Interface; 1994 May; 7(5):65-7, 70. PubMed ID: 10134345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialty pharmacy management adjusts to new financial realities.
    Reinke T
    Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
    [No Abstract]   [Full Text] [Related]  

  • 4. Need for integrated data in pharmacy benefits.
    Martens G; Clor GE
    J Health Care Benefits; 1993; 3(1):57-60. PubMed ID: 10130352
    [No Abstract]   [Full Text] [Related]  

  • 5. MCO-PBM (managed care organization-prescription benefit management) partnerships holding down drug trend.
    Alexander W
    Exec Solut Healthc Manag; 1998 Dec; 1(10):1, 4-6. PubMed ID: 10338773
    [No Abstract]   [Full Text] [Related]  

  • 6. Employers push to manage prescription drug costs.
    Frieden J
    Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of prescription costs--is it possible?
    Renaud PN
    Empl Benefits J; 2002 Mar; 27(1):11-4. PubMed ID: 11859536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pitfalls and potential of pharmacy risk.
    Lawrence J
    Manag Care; 1998 May; 7(5):45-6, 51-2. PubMed ID: 10180140
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling the cost of branded drugs.
    Mandelker J
    Bus Health; 1993 Nov; 11(13):44-6, 48. PubMed ID: 10130506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy carve-out offers cost control, computer modeling.
    Capitation Manag Rep; 2002 Jul; 9(7):103-8, 97. PubMed ID: 12164058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractual choice in the managed health care market. An empirical analysis.
    Csaba I; Fenn P
    J Health Econ; 1997 Oct; 16(5):579-88. PubMed ID: 10175632
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescription drug benefits: Rx for cost management--commentary.
    Carlsen MA
    Benefits Q; 1993; 9(3):81-8. PubMed ID: 10127207
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacy benefit management: the right Rx?
    Etheredge L
    Res Agenda Brief; 1995 Apr; (1):1-11. PubMed ID: 12856664
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies for health care cost containment.
    Mitchell GA
    Empl Benefits J; 1995 Jun; 20(2):18-22. PubMed ID: 10142520
    [No Abstract]   [Full Text] [Related]  

  • 16. Specialty pharmaceuticals: developing a management plan.
    Willcutts D
    Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifting gears.
    Tweed V
    Bus Health; 1994 May; 12(5):28-9, 32, 34 passim. PubMed ID: 10134334
    [No Abstract]   [Full Text] [Related]  

  • 18. PBMs raise the curtain.
    Sipkoff M
    Manag Care; 2006 Sep; 15(9):38-40, 43. PubMed ID: 17036937
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing the cost drivers of medical injectables.
    Johnson KA
    Manag Care Interface; 2003 Apr; 16(4):37-40. PubMed ID: 12747140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of upstream and downstream risk through selective contracting.
    Scammon DL; Fuller DA
    J Ambul Care Mark; 1992; 5(1):209-19. PubMed ID: 10122753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.